Code of Federal Regulations · Section
§ 312.87 — Active Monitoring Of Conduct And Evaluation Of Clinical Trials
21 C.F.R. § 312.87
View:
For drugs covered under this section, the Commissioner and other agency officials will monitor the progress of the conduct and evaluation of clinical trials and be involved in facilitating their appropriate progress.
Authorizing Statute
-
Adulterated drugs and devices21 U.S.C. § 351
-
Regulation of biological products42 U.S.C. § 262
-
Definitions; generally21 U.S.C. § 321